Status: Recruiting
Topical Infliximab in Eyes With Penetrating Keratoplasty
Penetrating keratoplasty is a cornea surgery involving several inflammatory complications, of which the most important is glaucoma. Researchers wish to determine whether it is safe to administer infliximab (an anti-inflammatory drug) eye drops after surgery, and whether this eye drop could prevent the occurrence of glaucoma.
Participants needed: 50
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Centre hospitalier de l'Université de Montréal (CHUM)Updated: Apr 27, 2026Locations: 1
Eligibility criteria
Age between 18 and 80 years; [+3]
Active ocular infection; [+10]